These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6320334)

  • 21. Surveillance of antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates from a central hospital in Portugal.
    Cardoso O; Alves AF; Leitão R
    J Antimicrob Chemother; 2007 Aug; 60(2):452-4. PubMed ID: 17576698
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for the next anti-Pseudomonas drug.
    Page MG; Heim J
    Curr Opin Pharmacol; 2009 Oct; 9(5):558-65. PubMed ID: 19748829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious complications in cancer patients treated with chemical immunosuppressive agents.
    Armstrong D
    Transplant Proc; 1973 Sep; 5(3):1245-8. PubMed ID: 4125683
    [No Abstract]   [Full Text] [Related]  

  • 25. R plasmids in the newborns: transfer of multiple antibiotic resistance from Pseudomonas aeruginosa to Enterobacteria.
    Seckárová A; Krcméry V; Havlík J
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(2):229-33. PubMed ID: 6432899
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].
    Kolker II; Stanislavskiĭ ES; Grishina IA; Panova IuM; Krokhina MA
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):29-33. PubMed ID: 6784114
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ocular infections Pyocyanic].
    Dufour D; Blervacque A; Malbrel PH
    Bull Soc Ophtalmol Fr; 1971; 71(9):900-4. PubMed ID: 5004862
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy of infections caused by Pseudomonas aeruginosa (pyocyanosis)].
    Chernomordik AB; Panchenko MK; Bulycheva NP
    Klin Med (Mosk); 1982 Jun; 60(6):17-20. PubMed ID: 6811797
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug sensitivity and pyocin typing of Pseudomonas aeruginesa strains from feces of infants with diarrhea].
    Swiderski M; Skrzypczak A
    Pediatr Pol; 1981; 56(11-12):1339-43. PubMed ID: 6803223
    [No Abstract]   [Full Text] [Related]  

  • 31. Clindamycin and metronidazole as independent risk factors for nosocomial acquisition of multidrug-resistant Pseudomonas aeruginosa.
    Cipriano Souza R; Vicente AC; Vieira VV; Marques SG; Soares Md; Moura MC; Koifman RJ
    J Hosp Infect; 2008 Aug; 69(4):402-3. PubMed ID: 18511147
    [No Abstract]   [Full Text] [Related]  

  • 32. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO; Mazumder SA
    J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
    [No Abstract]   [Full Text] [Related]  

  • 34. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
    Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type.
    Srifuengfung S; Tiensasitorn C; Yungyuen T; Dhiraputra C
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):893-6. PubMed ID: 15916087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
    Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
    Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract]   [Full Text] [Related]  

  • 38. [Management of an epidemic caused by Pseudomonas aeruginosa].
    Cencetti S; Martino G; Venditti M
    Ann Ig; 2000; 12(4 Suppl 2):123-5. PubMed ID: 11100562
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV; Gel'fand EB; Mamontova OA
    Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa.
    Cincă D; Meitert E; Tomescu E; Meitert T; Suciu M; Sima F; Savulian C; Midan F; Lică I
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.